Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
83.55
-0.56 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
84.96
+1.41 (1.69%)
After-hours: Apr 28, 2026, 7:08 PM EDT
Lantheus Holdings Revenue
In the year 2025, Lantheus Holdings had annual revenue of $1.54B with 0.50% growth. Lantheus Holdings had revenue of $406.79M in the quarter ending December 31, 2025, with 4.01% growth.
Revenue (ttm)
$1.54B
Revenue Growth
+0.50%
P/S Ratio
3.52
Revenue / Employee
$1,292,212
Employees
1,193
Market Cap
5.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 7.70M | 0.50% |
| Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
| Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
| Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
| Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.72B |
| Dr. Reddy's Laboratories | 3.85B |
| Amneal Pharmaceuticals | 3.02B |
| Neurocrine Biosciences | 2.86B |
| Hims & Hers Health | 2.35B |
| Alkermes | 1.48B |
| Prestige Consumer Healthcare | 1.10B |
| Supernus Pharmaceuticals | 718.95M |
LNTH News
- 6 weeks ago - Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) - GlobeNewsWire
- 7 weeks ago - Lantheus Holdings Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - GlobeNewsWire
- 2 months ago - Lantheus Holdings Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH - Business Wire
- 2 months ago - Lantheus Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time - GlobeNewsWire